Research advances in wogonin's anti-tumor effects

Journal of China Pharmaceutical University

Volumn 40, Issue 6, 2009, Pages 576-579

  Yang, Li ^a   You, Qi Dong ^a   Yang, Yong ^a   Guo, Qing Long ^a  

^a Jiangsu Key Laboratory of Carcinogenesis and Intervention   (China)

Author keywords

Angiogenesis; Apoptosis; Tumor; Wogonin

Indexed keywords

ANTINEOPLASTIC AGENT; FLAVONOID; WOGONIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL DEATH; DRUG POTENTIATION; HUMAN; RESEARCH; REVIEW;

EID: 75649118976     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Sonoda M, Nishiyama T, Matsukawa Y, et al. Cytotoxic activities of flavonoids from two Scutellaria plants in Chinese medicine [J]. J Ethnopharmacol,2004,91(1): 65-68.
2. Tang NY, Su CC, Chen GW, et al. Wogonin inhibits WEHI-3 leukemia cells in Blab/C mice in vivo [J]. FASEB J, 2007 21: A806.
3. Ma Z, Otsuyama K, Liu S, et al. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of prolif ration and induction of apoptosis in human myeloma cells[J]. Blood,2005,105(8): 3 312-3 318.
4. Chenn S. In vitro mechanism of PC SPES[J]. Urology,2001, 58 (2 Suppl 1): 28-35; discussion 38.
5. Chung VQ, Tattersall M, Cheung HT. Interactions of a herbal combination that inhibits growth of prostate cancer cells [J]. Cancer Chemother Pharmacol,2004,53(5): 384-390.
6. Bonham M, Posakony J, Coleman I, et al. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma[J]. Clin Cancer Res,2005,11(10): 3 905-3 914.
7. Chung H, Jung YM, Shin DH, et al. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts[J]. Int J Cancer,2008, 122(4): 816-822.
8. Wang W, Guo QL, You QD, et al. Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721[J]. Anticancer Drugs,2006,17(7): 797-805.
9. Wang W, Guo QL, You QD, et al. The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo[J]. Biol Pharm Bull,2006,29(6): 1 132-1 137.
10. Zhang SQ, Kovalenko A, Cantarella G, et al. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation[J]. Immunity, 2000,12(3) :301-311.
11. Fas SC, Baumann S, Zhu JY, et al. Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis[J]. Blood,2006,108(12): 3 700-3 706.
12. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword [J]. Nat Rev Immunol, 2003,3(9): 745 -756.
13. Muppidi JR, Tschopp J, Siegel RM. Life and death decisions; secondary complexes and lipid rafts in TNF receptor family signal transduction[J]. Immunity,2004,21(4): 461-465.
14. Trauzold A, Siegmund D, Schniewind B, et al. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma [J]. Oncogene, 2006,25(56): 7 434-7 439.
15. Daniel PT. A TRAIL to Chinese herbal medicine[J]. Blood, 2006,108(12): 3 634.
16. Yu JQ, Liu HB, Tian DZ, et al. Changes in mitochondrial membrane potential and reactive oxygen species during wogonin-induced cell death in human hepatoma cells [J]. Hepatol Res, 2007,37(1): 68-76.
17. Lee DH, Kim C, Zhang L, et al. Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells [J]. Biochem Pharmacol,2008,75(10): 2 020 -2 033.
18. 2+ -dependent apoptosis [J]. Blood,2008, 111(4): 2 354-2 363.
19. Lee E, Enomoto R, Suzuki C, et al. Wogonin, a plant flavone, potentiates etoposide-induced apoptosis in cancer cells[J]. Ann N Y Acad Sci,2007,1 095:521 -526.
20. Himeji M, Ohtsuki T, Fukazawa H, et al. Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell [J]. Cancer Lett,2007,245(1-2): 269-274.
21. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation [J]. Clin Sci (Lond),2005,108(3): 205-213.
22. Lin CM, Chang H, Chen YH, et al. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1[J]. Int Immunopharmacol,2006,6(11) :1 690-1 698.
23. Lu N, Gao Y, Ling Y, et al. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2[J]. Life Sci,2008,82(17-18): 956 -963.
24. Penning TM ,Jin Y, Steckelbroeck S, et al. Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins [J]. Mol Cell Endocrinol,2004,215(1-2): 63-72.
25. Chow KC, Lu MP, Wu MT. Expression of dihydrodiol dehydrogenase plays important roles in apoptosis and drug-resistance of A431 squamous cell carcinoma [J]. J Dermatol Sci, 2006,41 (3): 205-212.
26. Balkwill F, Mantovani A. Inflammation and cancer:back to Virchow[J]? Lancet,2001,357(9 255): 539-545.
27. Wang HW, Lin CP, Chiu JH, et al. Reversal of inflammation- associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin[J]. Int J Cancer,2007,120(9): 2 019-2 027.
28. Zhang K, Guo QL, You QD, et al. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression[J]. Cancer Sci,2008, 99(4): 689 -695.
29. Zhang HW, Yang Y, Zhang K, et al. Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCdelta phosphorylation [J]. Eur J Pharmacol, 2008, 591 (1-3): 7-12.